Following test is used to assess the warfarin dose?
**Core Concept**
Warfarin is an anticoagulant medication that works by inhibiting vitamin K-dependent clotting factors in the liver. To ensure safe and effective anticoagulation, monitoring of warfarin dose is necessary, which involves assessing the International Normalized Ratio (INR) of the patient's prothrombin time.
**Why the Correct Answer is Right**
The test used to assess the warfarin dose is the prothrombin time (PT) test, which measures the time it takes for blood to clot. The INR is a calculated value derived from the PT test that standardizes the results across different laboratories and reagents. Warfarin increases the PT due to its inhibition of vitamin K-dependent clotting factors (II, VII, IX, and X) in the liver, and the goal of therapy is to maintain an INR within a target range to prevent thrombotic events.
**Why Each Wrong Option is Incorrect**
**Option A:** There is no evidence to support the use of activated partial thromboplastin time (aPTT) as a primary test for monitoring warfarin dose. Although warfarin may have some effect on aPTT, it is not a reliable indicator of its anticoagulant effect.
**Option B:** The bleeding time test is not relevant to the assessment of warfarin dose. Warfarin affects the coagulation cascade, not platelet function, which is what bleeding time tests measure.
**Option C:** The d-dimer test is not used to assess warfarin dose. It is a test used to detect fibrin degradation products and is useful in diagnosing thrombotic disorders, but it is not a reliable indicator of anticoagulation status.
**Clinical Pearl / High-Yield Fact**
Warfarin therapy requires regular monitoring of INR to prevent both thrombotic and bleeding complications. It is essential to maintain an INR within a target range (usually 2.0-3.0) to ensure effective anticoagulation without increasing the risk of bleeding.
**Correct Answer: D. Prothrombin Time (PT) test.**